Global Drug Repositioning Market Insights and Forecast to 2031

Report ID: 1226406 | Published Date: Jan 2025 | No. of Page: 107 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Business Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Drug Repositioning Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Generic Drugs
        1.2.3 Clinical Trial Failed Drugs
    1.3 Market by Application
        1.3.1 Global Drug Repositioning Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Cardiovascular Diseases
        1.3.3 Mental Illness
        1.3.4 Cancer
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Drug Repositioning Market Perspective (2017-2028)
    2.2 Drug Repositioning Growth Trends by Region
        2.2.1 Drug Repositioning Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Drug Repositioning Historic Market Size by Region (2017-2022)
        2.2.3 Drug Repositioning Forecasted Market Size by Region (2023-2028)
    2.3 Drug Repositioning Market Dynamics
        2.3.1 Drug Repositioning Industry Trends
        2.3.2 Drug Repositioning Market Drivers
        2.3.3 Drug Repositioning Market Challenges
        2.3.4 Drug Repositioning Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Drug Repositioning Players by Revenue
        3.1.1 Global Top Drug Repositioning Players by Revenue (2017-2022)
        3.1.2 Global Drug Repositioning Revenue Market Share by Players (2017-2022)
    3.2 Global Drug Repositioning Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Drug Repositioning Revenue
    3.4 Global Drug Repositioning Market Concentration Ratio
        3.4.1 Global Drug Repositioning Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Drug Repositioning Revenue in 2021
    3.5 Drug Repositioning Key Players Head office and Area Served
    3.6 Key Players Drug Repositioning Product Solution and Service
    3.7 Date of Enter into Drug Repositioning Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Repositioning Breakdown Data by Type
    4.1 Global Drug Repositioning Historic Market Size by Type (2017-2022)
    4.2 Global Drug Repositioning Forecasted Market Size by Type (2023-2028)
5 Drug Repositioning Breakdown Data by Application
    5.1 Global Drug Repositioning Historic Market Size by Application (2017-2022)
    5.2 Global Drug Repositioning Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Drug Repositioning Market Size (2017-2028)
    6.2 North America Drug Repositioning Market Size by Type
        6.2.1 North America Drug Repositioning Market Size by Type (2017-2022)
        6.2.2 North America Drug Repositioning Market Size by Type (2023-2028)
        6.2.3 North America Drug Repositioning Market Share by Type (2017-2028)
    6.3 North America Drug Repositioning Market Size by Application
        6.3.1 North America Drug Repositioning Market Size by Application (2017-2022)
        6.3.2 North America Drug Repositioning Market Size by Application (2023-2028)
        6.3.3 North America Drug Repositioning Market Share by Application (2017-2028)
    6.4 North America Drug Repositioning Market Size by Country
        6.4.1 North America Drug Repositioning Market Size by Country (2017-2022)
        6.4.2 North America Drug Repositioning Market Size by Country (2023-2028)
        6.4.3 United States
        6.4.4 Canada
7 Europe
    7.1 Europe Drug Repositioning Market Size (2017-2028)
    7.2 Europe Drug Repositioning Market Size by Type
        7.2.1 Europe Drug Repositioning Market Size by Type (2017-2022)
        7.2.2 Europe Drug Repositioning Market Size by Type (2023-2028)
        7.2.3 Europe Drug Repositioning Market Share by Type (2017-2028)
    7.3 Europe Drug Repositioning Market Size by Application
        7.3.1 Europe Drug Repositioning Market Size by Application (2017-2022)
        7.3.2 Europe Drug Repositioning Market Size by Application (2023-2028)
        7.3.3 Europe Drug Repositioning Market Share by Application (2017-2028)
    7.4 Europe Drug Repositioning Market Size by Country
        7.4.1 Europe Drug Repositioning Market Size by Country (2017-2022)
        7.4.2 Europe Drug Repositioning Market Size by Country (2023-2028)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Drug Repositioning Market Size (2017-2028)
    8.2 Asia-Pacific Drug Repositioning Market Size by Type
        8.2.1 Asia-Pacific Drug Repositioning Market Size by Type (2017-2022)
        8.2.2 Asia-Pacific Drug Repositioning Market Size by Type (2023-2028)
        8.2.3 Asia-Pacific Drug Repositioning Market Share by Type (2017-2028)
    8.3 Asia-Pacific Drug Repositioning Market Size by Application
        8.3.1 Asia-Pacific Drug Repositioning Market Size by Application (2017-2022)
        8.3.2 Asia-Pacific Drug Repositioning Market Size by Application (2023-2028)
        8.3.3 Asia-Pacific Drug Repositioning Market Share by Application (2017-2028)
    8.4 Asia-Pacific Drug Repositioning Market Size by Region
        8.4.1 Asia-Pacific Drug Repositioning Market Size by Region (2017-2022)
        8.4.2 Asia-Pacific Drug Repositioning Market Size by Region (2023-2028)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia 
9 Latin America
    9.1 Latin America Drug Repositioning Market Size (2017-2028)
    9.2 Latin America Drug Repositioning Market Size by Type
        9.2.1 Latin America Drug Repositioning Market Size by Type (2017-2022)
        9.2.2 Latin America Drug Repositioning Market Size by Type (2023-2028)
        9.2.3 Latin America Drug Repositioning Market Share by Type (2017-2028)
    9.3 Latin America Drug Repositioning Market Size by Application
        9.3.1 Latin America Drug Repositioning Market Size by Application (2017-2022)
        9.3.2 Latin America Drug Repositioning Market Size by Application (2023-2028)
        9.3.3 Latin America Drug Repositioning Market Share by Application (2017-2028)
    9.4 Latin America Drug Repositioning Market Size by Country
        9.4.1 Latin America Drug Repositioning Market Size by Country (2017-2022)
        9.4.2 Latin America Drug Repositioning Market Size by Country (2023-2028)
        9.4.3 Mexico
        9.4.4 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Drug Repositioning Market Size (2017-2028)
    10.2 Middle East & Africa Drug Repositioning Market Size by Type
        10.2.1 Middle East & Africa Drug Repositioning Market Size by Type (2017-2022)
        10.2.2 Middle East & Africa Drug Repositioning Market Size by Type (2023-2028)
        10.2.3 Middle East & Africa Drug Repositioning Market Share by Type (2017-2028)
    10.3 Middle East & Africa Drug Repositioning Market Size by Application
        10.3.1 Middle East & Africa Drug Repositioning Market Size by Application (2017-2022)
        10.3.2 Middle East & Africa Drug Repositioning Market Size by Application (2023-2028)
        10.3.3 Middle East & Africa Drug Repositioning Market Share by Application (2017-2028)
    10.4 Middle East & Africa Drug Repositioning Market Size by Country
        10.4.1 Middle East & Africa Drug Repositioning Market Size by Country (2017-2022)
        10.4.2 Middle East & Africa Drug Repositioning Market Size by Country (2023-2028)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE
11 Key Players Profiles
    11.1 Teva
        11.1.1 Teva Company Details
        11.1.2 Teva Business Overview
        11.1.3 Teva Drug Repositioning Introduction
        11.1.4 Teva Revenue in Drug Repositioning Business (2017-2022)
        11.1.5 Teva Recent Developments
    11.2 Novartis
        11.2.1 Novartis Company Details
        11.2.2 Novartis Business Overview
        11.2.3 Novartis Drug Repositioning Introduction
        11.2.4 Novartis Revenue in Drug Repositioning Business (2017-2022)
        11.2.5 Novartis Recent Developments
    11.3 Mylan
        11.3.1 Mylan Company Details
        11.3.2 Mylan Business Overview
        11.3.3 Mylan Drug Repositioning Introduction
        11.3.4 Mylan Revenue in Drug Repositioning Business (2017-2022)
        11.3.5 Mylan Recent Developments
    11.4 Johnson & Johnson
        11.4.1 Johnson & Johnson Company Details
        11.4.2 Johnson & Johnson Business Overview
        11.4.3 Johnson & Johnson Drug Repositioning Introduction
        11.4.4 Johnson & Johnson Revenue in Drug Repositioning Business (2017-2022)
        11.4.5 Johnson & Johnson Recent Developments
    11.5 Pfizer
        11.5.1 Pfizer Company Details
        11.5.2 Pfizer Business Overview
        11.5.3 Pfizer Drug Repositioning Introduction
        11.5.4 Pfizer Revenue in Drug Repositioning Business (2017-2022)
        11.5.5 Pfizer Recent Developments
    11.6 Bausch Health
        11.6.1 Bausch Health Company Details
        11.6.2 Bausch Health Business Overview
        11.6.3 Bausch Health Drug Repositioning Introduction
        11.6.4 Bausch Health Revenue in Drug Repositioning Business (2017-2022)
        11.6.5 Bausch Health Recent Developments
    11.7 GSK
        11.7.1 GSK Company Details
        11.7.2 GSK Business Overview
        11.7.3 GSK Drug Repositioning Introduction
        11.7.4 GSK Revenue in Drug Repositioning Business (2017-2022)
        11.7.5 GSK Recent Developments
    11.8 ChemRar Group
        11.8.1 ChemRar Group Company Details
        11.8.2 ChemRar Group Business Overview
        11.8.3 ChemRar Group Drug Repositioning Introduction
        11.8.4 ChemRar Group Revenue in Drug Repositioning Business (2017-2022)
        11.8.5 ChemRar Group Recent Developments
    11.9 Glenmark
        11.9.1 Glenmark Company Details
        11.9.2 Glenmark Business Overview
        11.9.3 Glenmark Drug Repositioning Introduction
        11.9.4 Glenmark Revenue in Drug Repositioning Business (2017-2022)
        11.9.5 Glenmark Recent Developments
    11.10 Fujifilm
        11.10.1 Fujifilm Company Details
        11.10.2 Fujifilm Business Overview
        11.10.3 Fujifilm Drug Repositioning Introduction
        11.10.4 Fujifilm Revenue in Drug Repositioning Business (2017-2022)
        11.10.5 Fujifilm Recent Developments
    11.11 Dr. Reddy
        11.11.1 Dr. Reddy Company Details
        11.11.2 Dr. Reddy Business Overview
        11.11.3 Dr. Reddy Drug Repositioning Introduction
        11.11.4 Dr. Reddy Revenue in Drug Repositioning Business (2017-2022)
        11.11.5 Dr. Reddy Recent Developments
    11.12 R-Pharma
        11.12.1 R-Pharma Company Details
        11.12.2 R-Pharma Business Overview
        11.12.3 R-Pharma Drug Repositioning Introduction
        11.12.4 R-Pharma Revenue in Drug Repositioning Business (2017-2022)
        11.12.5 R-Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Author Details
    13.3 Disclaimer

List of Tables
    Table 1. Global Drug Repositioning Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Generic Drugs
    Table 3. Key Players of Clinical Trial Failed Drugs
    Table 4. Global Drug Repositioning Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 5. Global Drug Repositioning Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Drug Repositioning Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Drug Repositioning Market Share by Region (2017-2022)
    Table 8. Global Drug Repositioning Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Drug Repositioning Market Share by Region (2023-2028)
    Table 10. Drug Repositioning Market Trends
    Table 11. Drug Repositioning Market Drivers
    Table 12. Drug Repositioning Market Challenges
    Table 13. Drug Repositioning Market Restraints
    Table 14. Global Drug Repositioning Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Drug Repositioning Revenue Share by Players (2017-2022)
    Table 16. Global Top Drug Repositioning by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2021)
    Table 17. Ranking of Global Top Drug Repositioning Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Drug Repositioning Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Drug Repositioning Product Solution and Service
    Table 21. Date of Enter into Drug Repositioning Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Drug Repositioning Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Drug Repositioning Revenue Market Share by Type (2017-2022)
    Table 25. Global Drug Repositioning Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Drug Repositioning Revenue Market Share by Type (2023-2028)
    Table 27. Global Drug Repositioning Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Drug Repositioning Revenue Share by Application (2017-2022)
    Table 29. Global Drug Repositioning Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Drug Repositioning Revenue Share by Application (2023-2028)
    Table 31. North America Drug Repositioning Market Size by Type (2017-2022) & (US$ Million)
    Table 32. North America Drug Repositioning Market Size by Type (2023-2028) & (US$ Million)
    Table 33. North America Drug Repositioning Market Size by Application (2017-2022) & (US$ Million)
    Table 34. North America Drug Repositioning Market Size by Application (2023-2028) & (US$ Million)
    Table 35. North America Drug Repositioning Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Drug Repositioning Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Drug Repositioning Market Size by Type (2017-2022) & (US$ Million)
    Table 38. Europe Drug Repositioning Market Size by Type (2023-2028) & (US$ Million)
    Table 39. Europe Drug Repositioning Market Size by Application (2017-2022) & (US$ Million)
    Table 40. Europe Drug Repositioning Market Size by Application (2023-2028) & (US$ Million)
    Table 41. Europe Drug Repositioning Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Europe Drug Repositioning Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Asia Pacific Drug Repositioning Market Size by Type (2017-2022) & (US$ Million)
    Table 44. Asia Pacific Drug Repositioning Market Size by Type (2023-2028) & (US$ Million)
    Table 45. Asia Pacific Drug Repositioning Market Size by Application (2017-2022) & (US$ Million)
    Table 46. Asia Pacific Drug Repositioning Market Size by Application (2023-2028) & (US$ Million)
    Table 47. Asia Pacific Drug Repositioning Market Size by Region (2017-2022) & (US$ Million)
    Table 48. Asia Pacific Drug Repositioning Market Size by Region (2023-2028) & (US$ Million)
    Table 49. Latin America Drug Repositioning Market Size by Type (2017-2022) & (US$ Million)
    Table 50. Latin America Drug Repositioning Market Size by Type (2023-2028) & (US$ Million)
    Table 51. Latin America Drug Repositioning Market Size by Application (2017-2022) & (US$ Million)
    Table 52. Latin America Drug Repositioning Market Size by Application (2023-2028) & (US$ Million)
    Table 53. Latin America Drug Repositioning Market Size by Country (2017-2022) & (US$ Million)
    Table 54. Latin America Drug Repositioning Market Size by Country (2023-2028) & (US$ Million)
    Table 55. Middle East and Africa Drug Repositioning Market Size by Type (2017-2022) & (US$ Million)
    Table 56. Middle East and Africa Drug Repositioning Market Size by Type (2023-2028) & (US$ Million)
    Table 57. Middle East and Africa Drug Repositioning Market Size by Application (2017-2022) & (US$ Million)
    Table 58. Middle East and Africa Drug Repositioning Market Size by Application (2023-2028) & (US$ Million)
    Table 59. Middle East and Africa Drug Repositioning Market Size by Country (2017-2022) & (US$ Million)
    Table 60. Middle East and Africa Drug Repositioning Market Size by Country (2023-2028) & (US$ Million)
    Table 61. Teva Company Details
    Table 62. Teva Business Overview
    Table 63. Teva Drug Repositioning Product
    Table 64. Teva Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 65. Teva Recent Developments
    Table 66. Novartis Company Details
    Table 67. Novartis Business Overview
    Table 68. Novartis Drug Repositioning Product
    Table 69. Novartis Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 70. Novartis Recent Developments
    Table 71. Mylan Company Details
    Table 72. Mylan Business Overview
    Table 73. Mylan Drug Repositioning Product
    Table 74. Mylan Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 75. Mylan Recent Developments
    Table 76. Johnson & Johnson Company Details
    Table 77. Johnson & Johnson Business Overview
    Table 78. Johnson & Johnson Drug Repositioning Product
    Table 79. Johnson & Johnson Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 80. Johnson & Johnson Recent Developments
    Table 81. Pfizer Company Details
    Table 82. Pfizer Business Overview
    Table 83. Pfizer Drug Repositioning Product
    Table 84. Pfizer Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 85. Pfizer Recent Developments
    Table 86. Bausch Health Company Details
    Table 87. Bausch Health Business Overview
    Table 88. Bausch Health Drug Repositioning Product
    Table 89. Bausch Health Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 90. Bausch Health Recent Developments
    Table 91. GSK Company Details
    Table 92. GSK Business Overview
    Table 93. GSK Drug Repositioning Product
    Table 94. GSK Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 95. GSK Recent Developments
    Table 96. ChemRar Group Company Details
    Table 97. ChemRar Group Business Overview
    Table 98. ChemRar Group Drug Repositioning Product
    Table 99. ChemRar Group Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 100. ChemRar Group Recent Developments
    Table 101. Glenmark Company Details
    Table 102. Glenmark Business Overview
    Table 103. Glenmark Drug Repositioning Product
    Table 104. Glenmark Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 105. Glenmark Recent Developments
    Table 106. Fujifilm Company Details
    Table 107. Fujifilm Business Overview
    Table 108. Fujifilm Drug Repositioning Product
    Table 109. Fujifilm Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 110. Fujifilm Recent Developments
    Table 111. Dr. Reddy Company Details
    Table 112. Dr. Reddy Business Overview
    Table 113. Dr. Reddy Drug Repositioning Product
    Table 114. Dr. Reddy Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 115. Dr. Reddy Recent Developments
    Table 116. R-Pharma Company Details
    Table 117. R-Pharma Business Overview
    Table 118. R-Pharma Drug Repositioning Product
    Table 119. R-Pharma Revenue in Drug Repositioning Business (2017-2022) & (US$ Million)
    Table 120. R-Pharma Recent Developments
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Drug Repositioning Market Share by Type: 2021 VS 2028
    Figure 2. Generic Drugs Features
    Figure 3. Clinical Trial Failed Drugs Features
    Figure 4. Global Drug Repositioning Market Share by Application: 2021 VS 2028
    Figure 5. Cardiovascular Diseases Case Studies
    Figure 6. Mental Illness Case Studies
    Figure 7. Cancer Case Studies
    Figure 8. Others Case Studies
    Figure 9. Drug Repositioning Report Years Considered
    Figure 10. Global Drug Repositioning Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Drug Repositioning Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Drug Repositioning Market Share by Region: 2021 VS 2028
    Figure 13. Global Drug Repositioning Market Share by Players in 2021
    Figure 14. Global Top Drug Repositioning Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug Repositioning as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Drug Repositioning Revenue in 2021
    Figure 16. North America Drug Repositioning Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Drug Repositioning Market Size Market Share by Type (2017-2028)
    Figure 18. North America Drug Repositioning Market Size Market Share by Application (2017-2028)
    Figure 19. North America Drug Repositioning Market Size Share by Country (2017-2028)
    Figure 20. United States Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Drug Repositioning Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Drug Repositioning Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Drug Repositioning Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Drug Repositioning Market Size Share by Country (2017-2028)
    Figure 26. Germany Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Drug Repositioning Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Drug Repositioning Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Drug Repositioning Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Drug Repositioning Market Size Share by Region (2017-2028)
    Figure 36. China Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Latin America Drug Repositioning Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Drug Repositioning Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Drug Repositioning Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Drug Repositioning Market Size Share by Country (2017-2028)
    Figure 46. Mexico Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Drug Repositioning Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Drug Repositioning Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Drug Repositioning Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Drug Repositioning Market Size Share by Country (2017-2028)
    Figure 52. Turkey Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Drug Repositioning Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Teva Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 57. Mylan Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 58. Johnson & Johnson Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 59. Pfizer Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 60. Bausch Health Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 61. GSK Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 62. ChemRar Group Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 63. Glenmark Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 64. Fujifilm Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 65. Dr. Reddy Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 66. R-Pharma Revenue Growth Rate in Drug Repositioning Business (2017-2022)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Teva
Novartis
Mylan
Johnson & Johnson
Pfizer
Bausch Health
GSK
ChemRar Group
Glenmark
Fujifilm
Dr. Reddy
R-Pharma
Frequently Asked Questions
Drug Repositioning report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Drug Repositioning report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Drug Repositioning report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Aerospace Coatings

Aerospace Coatings market is segmented by Type and by Application. Players, stakeholders, and oth ... Read More